Yoga guru Ramdev on Friday released a research paper by Haridwar-based Patanjali Research Institute on the "first evidence-based ayurvedic medicine" against the coronavirus disease, Coronil. It is to be noted that the same medicine had come under AYUSH ministry's lens last year after it was launched with a claim to treat COVID-19, months before the world's first vaccine was rolled out.
At the time of the launch of the medicine, the claim had been scoffed at by the AYUSH Ministry, which had asked the company to stop advertisements for the drug until the issue had been examined. The AYUSH ministry had also sought a detailed report on composition, testing and other data for the drug. The Centre had barred the firm from advertising the products after Ramdev said they cured 280 patients within days in trials. Coronil was then passed as "Immuno-booster" only.
On Friday, however, Patanjali stated that Coronil has now received certification from Ayush Ministry as per World Health Organization (WHO) certification scheme. "Coronil has received the Certificate of Pharmaceutical Product (CoPP) from the Ayush section of Central Drugs Standard Control Organisation as per the WHO certification scheme," said Patanjali in a statement.
also read
- Patanjali ad case: SC gives Baba Ramdev, Balkrishna one-week time to offer public apology
- 'We will rip you apart': SC slams Uttarakhand govt for not taking action against Patanjali for false ads
- Baba Ramdev’s apology ‘mere lip service’, must appear for next hearing: SC in Patanjali ad case
- Pathanjali submits affidavit in Supreme Court, says misleading ads won't appear in future
Union health minister Harsh Vardhan and Union transport minister Nitin Gadkari were also present at the event.
Under CoPP, Coronil can now be exported to 158 countries. On the basis of presented data, the Ministry of Ayush has recognised Coronil Tablet as a medicine for "supporting measures in Covid-19."
Harsh Vardhan said at the event, "Ayurveda has Rs 30,000 crore economy in India. As per official data, it used to see a growth of 15-20 per cent every year pre-coronavirus. Post-Covid, this growth rate has risen to 50-90 per cent. It's an indication that people have accepted it. There's marked improvement in exports and FDI."
